Symbols / ALGS $6.51 -0.76% Aligos Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
ALGS Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 40.28M Enterprise Value -32.00M Income -24.19M Sales 2.19M Book/sh 8.67 Cash/sh 12.58
Dividend Yield — Payout 0.00% Employees 82 IPO — P/E — Forward P/E -1.34
PEG — P/S 18.43 P/B 0.75 P/C — EV/EBITDA 0.37 EV/Sales -14.64
Quick Ratio 3.67 Current Ratio 3.90 Debt/Eq 9.80 LT Debt/Eq — EPS (ttm) -2.45 EPS next Y -4.85
EPS Growth — Revenue Growth -73.10% Earnings 2026-05-05 ROA -69.33% ROE -196.91% ROIC —
Gross Margin 0.00% Oper. Margin -129.08% Profit Margin 0.00% Shs Outstand 5.39M Shs Float 3.64M Short Float 5.81%
Short Ratio 7.02 Short Interest — 52W High 13.69 52W Low 4.20 Beta 2.62 Avg Volume 165.10K
Volume 177.69K Target Price $65.80 Recom Strong_buy Prev Close $6.56 Price $6.51 Change -0.76%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-167.18
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest ALGS news

No recent news from Yahoo. Try the RSS feed for latest ALGS news.

Insider Transactions

No recent insider transactions.

Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category